Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

NVR Q1 Profit Rises - Quick Facts

RELATED NEWS
Trade NVR now with 

NVR Inc. (NVR: Quote) announced first-quarter net income of $20.12 million $3.90 per share, up from $15.17 million or $2.52 per share in the same quarter last year.

Homebuilding revenues rose to $586.20 million from $502.74 million in the year ago quarter. Consolidated revenues for the first quarter totaled $600.49 million, a 17% increase from $514.50 million for the comparable 2011 quarter.

New orders in the first quarter of 2012 increased 31% to 3,157 units, when compared to 2,403 units in the first quarter of 2011. The cancellation rate in the first quarter of 2012 was 10.3% compared to 12.3% in the first quarter of 2011 and 14.9% in the fourth quarter of 2011.

Analysts polled by Thomson Reuters expected the company to report earnings of $4.16 per share on revenues of $611.98 million for the quarter. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for NVR Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved sharply lower over the course of the trading day on Wednesday, adding to the modest weakness seen in the two previous sessions. With the losses on the day, the major averages fell to their lowest closing levels in over a month. Democrats have climbed into the lead on a generic ballot, according to the results of a new CNN/ORC International poll, although the results may not be as positive for the party as they first appear. With spending on private and public construction both showing notable decreases, the Commerce Department released a report on Wednesday showing an unexpected drop in U.S. construction spending in the month of August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.